![]() | ![]() From the manuscript Cerebrotendinous xanthomatosis - The spectrum of imaging findings ![]() Abstract | ![]() |
![]() | 1. Barkhof F, Verrips A, Wesseling P. Cerebrotendinous xanthomatosis: the spectrum of imaging findings and the correlation with neuropathologic findings.Radiology 2000; 217: 869- 876. ![]() ![]() Find similar topics on ![]() ![]() ![]() 2. Dotti MT, Federico A, Signorini E. AJNR Am J Neuroradiol 1994; 15:1721-1726. ![]() ![]() Find similar topics on ![]() ![]() ![]() 3. Chatterjee G, Chakraborty I, Das TK, Datta C. Cerebrotendinous xanthomatosis in a family. Indian J Dermatol 1999; 44(3):153-6. Find similar topics on ![]() ![]() ![]() 4. Berginer VM, Salen G, Shefer S. Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. N Engl J Med.1984;311:1649-52 ![]() ![]() Find similar topics on ![]() ![]() ![]() 5. Gallus GN, Dotti MT, Federico A. Clinical and molecular diagnosis of cerebrotendinous xanthomatosis with a review of the mutations in the CYP27A1 gene. Neurol Sci 2006;27:143-9 ![]() ![]() Find similar topics on ![]() ![]() ![]() 6. Moghadasian MH. Cerebrotendinous xanthomatosis: clinical course, genotypes and metabolic backgrounds. Clin Invest Med 2004;27:42-50 ![]() ![]() Find similar topics on ![]() ![]() ![]() 7. Cruysberg JR, Wevers RA, Tolboom JJ. Juvenile cataract associated with chronic diarrhea in pediatriccerebrotendinous xanthomatosis. Am J Ophthal 1991;112 ![]() ![]() Find similar topics on ![]() ![]() ![]() 8. Dotti MT, Lütjohann D, von Bergmann K, Federico A. Normalisation of serum cholestanol concentration in a patient with cerebrotendinous xanthomatosis by combined treatment with chenodeoxycholic acid, simvastatin and LDL apheresis. Neurol Sci 2004;25:185-91 ![]() ![]() Find similar topics on ![]() ![]() ![]() 9. Kuriyama M, Tokimura Y, Fujiyama J, Utatsu Y, Osame M. Treatment of cerebrotendinous xanthomatosis: effects of chenodeoxycholic acid, pravastatin, and combined use. J Neurol Sci 1994;125:22-8 ![]() ![]() Find similar topics on ![]() ![]() ![]() 10. Berginer VM, Berginer J, KorczynAD,Tadmor R. Magnetic resonance imaging in cerebrotendinous xanthomatosis: aprospective clinical and neuroradiological study. J NeurolSci 1994; 122:102-108 ![]() ![]() Find similar topics on ![]() ![]() ![]() 11. Verrips A, Nijeholt GJ, Barkhof F. Spinal xanthomatosis: a variant of cerebrotendinous xanthomatosis. Brain 1999;122:1589-1595 ![]() ![]() Find similar topics on ![]() ![]() ![]() 12. Federico A, Dotti MT. Cerebrotendinous xanthomatosis: clinical manifestations, diagnostic criteria, pathogenesis, and therapy. J Child Neurol 2003 Sep;18(9):633-8 ![]() ![]() Find similar topics on ![]() ![]() ![]() 13. Salen G, Berginer V, Shore V. Increased concentrations of cholestanol and apolipoprotein B in the cerebrospinal ?uid of patients with cerebrotendinous xanthomatosis: effect of chenodeoxycholic acid. N Engl J Med 1987 May 14;316(20):1233-8 ![]() ![]() Find similar topics on ![]() ![]() ![]() | ![]() |
![]() | Keyword search: 1. Cerebrotendinous xanthomatosis 2. CTX 3. Cholestanol 4. CYP27A1 5. Chenodeoxycholic acid This article belongs to the Neuro section. | ![]() |